HOOKIPA Pharma (NASDAQ:HOOK) Shares Down 0% – Should You Sell?

Shares of HOOKIPA Pharma Inc. (NASDAQ:HOOK) dropped 0% on Tuesday . The stock traded as low as $1.01 and last traded at $1.01. Approximately 526 shares traded hands during trading, a decline of 94% from the average daily volume of 8,102 shares. The stock had previously closed at $1.0101.

HOOKIPA Pharma Stock Down 0.8%

The company’s 50-day moving average is $0.97 and its 200-day moving average is $0.92. The stock has a market capitalization of $12.70 million, a price-to-earnings ratio of -0.18 and a beta of 0.92.

About HOOKIPA Pharma

HOOKIPA Pharma Inc is a clinical-stage biotechnology company focused on the development of virus-based immunotherapies and vaccines. The company operates two complementary platform technologies—an engineered Modified Vaccinia Ankara (MVA) vector and an arenavirus vector system—designed to stimulate both humoral and cellular immune responses. By combining these platforms, HOOKIPA aims to address infectious diseases and drive novel immuno-oncology treatments.

In the infectious disease arena, HOOKIPA’s pipeline includes prophylactic vaccine candidates targeting pathogens such as cytomegalovirus (CMV) in transplant settings and other viral threats.